Brief: Idera Pharmaceuticals Reports Q2 Loss Per Share $0.39

Aceragen

08/08/2019 14:08

Aug 8 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND
REPORTS
SECOND QUARTER 2019 FINANCIAL RESULTS
    * Q2 LOSS PER SHARE $0.39
    * Q2 REVENUE $1.4 MILLION VERSUS $200,000
    * Q2 REVENUE ESTIMATE $0 -- REFINITIV IBES DATA
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.42 -- REFINITIV IBES
DATA
    * AS OF JUNE 30, 2019, CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS TOTALED $52.4 MILLION

Source text for Eikon:  ID:nGNX1zLdR4 
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))